BIO'OR is a food producer in Poperinge. Public Limited, started on 5 June 2012, 2 establishments.

What is the address of BIO'OR?

The registered office of BIO'OR is located at Vlamertingseweg 33, 8970 Poperinge.

Is BIO'OR still active?

Yes. According to the CBE (29 October 2026) BIO'OR is active, legal situation “Normale toestand”, started on 5 June 2012.

Is BIO'OR registered on Peppol?

Yes, BIO'OR is registered on the Peppol network with ID 0208:0846356672.

What is the enterprise number of BIO'OR?

The enterprise number of BIO'OR is BE0846356672.

When was BIO'OR founded?

BIO'OR was founded on 5 June 2012.

Who are the directors of BIO'OR?

According to the 2025 annual accounts, the directors of BIO'OR are: Rik Vandeputte, Dries Ghekiere, Francis Vandeputte, Marnik Vanrolleghem.

Is BIO'OR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 June 2012; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account; 2 establishments in the CBE.

How much profit did BIO'OR make in 2025?

BIO'OR posted a profit after taxes of € 326,048 in financial year 2025.

What is the revenue of BIO'OR?

As a small company, BIO'OR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 743,411.

How much does an employee at BIO'OR earn?

The average wage cost per full-time employee at BIO'OR was € 74,600 in 2025: staff costs of € 201,538 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BIO'OR have?

According to the 2025 annual accounts, BIO'OR has 2.7 full-time equivalents (FTE).

BIO'OR (Public Limited) - Poperinge - BE0846356672

Dossier BIO'OR, printed on 29 October 2026 from databakkes.be/en/0846356672/bio-or. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BIO'OR from Poperinge, company number BE0846356672, closed financial year 2025 with a result of € 326,048 after tax. For that financial year BIO'OR recorded a gross margin of € 743,411 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € 317,260 to € 326,048. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 19, 2025.

What it is worth Growing

€ 1.6 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 326,048

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 130,502

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,000 paid out

46 % of the profit went to the shareholders, mostly to LYSINVEST (70 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.7

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 201,538

▲ 5% vs 2024

€ 74,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 235,000

▼ 60% vs 2024

€ 90,000 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 802,609

▲ 60% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 75,664

▲ 111% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 462,206 Gross margin 2022: € 462,206 First fiscal year in the series	€ 509,521 Gross margin 2023: € 509,521 ▲ 10% vs 2022 (€ 462,206) Favourable step	€ 733,141 Gross margin 2024: € 733,141 ▲ 44% vs 2023 (€ 509,521) Favourable step	€ 743,411 Gross margin 2025: € 743,411 ▲ 1% vs 2024 (€ 733,141) Favourable step	▲ 1%
Profit after taxes	€ 121,240 Profit after taxes 2022: € 121,240 First fiscal year in the series	€ 181,902 Profit after taxes 2023: € 181,902 ▲ 50% vs 2022 (€ 121,240) Favourable step	€ 317,260 Profit after taxes 2024: € 317,260 ▲ 74% vs 2023 (€ 181,902) Favourable step	€ 326,048 Profit after taxes 2025: € 326,048 ▲ 3% vs 2024 (€ 317,260) Favourable step	▲ 3%
Equity	€ 1,055,494 Equity 2022: € 1,055,494 First fiscal year in the series	€ 1,237,396 Equity 2023: € 1,237,396 ▲ 17% vs 2022 (€ 1,055,494) Favourable step	€ 1,404,656 Equity 2024: € 1,404,656 ▲ 14% vs 2023 (€ 1,237,396) Favourable step	€ 1,580,704 Equity 2025: € 1,580,704 ▲ 13% vs 2024 (€ 1,404,656) Favourable step	▲ 13%
Total debts	€ 1,831,964 Total debts 2022: € 1,831,964 First fiscal year in the series	€ 2,019,249 Total debts 2023: € 2,019,249 ▲ 10% vs 2022 (€ 1,831,964) Unfavourable step	€ 1,576,557 Total debts 2024: € 1,576,557 ▼ 22% vs 2023 (€ 2,019,249) Favourable step	€ 1,587,732 Total debts 2025: € 1,587,732 ▲ 1% vs 2024 (€ 1,576,557) Unfavourable step	▲ 1%
Cash	€ 25,322 Cash 2022: € 25,322 First fiscal year in the series	€ 243,854 Cash 2023: € 243,854 ▲ € 218,532 vs 2022 (€ 25,322) Favourable step	€ 110,394 Cash 2024: € 110,394 ▼ 55% vs 2023 (€ 243,854) Unfavourable step	€ 130,502 Cash 2025: € 130,502 ▲ 18% vs 2024 (€ 110,394) Favourable step	▲ 18%
Retained profit	€ 305,494 Retained profit 2022: € 305,494 First fiscal year in the series	€ 487,396 Retained profit 2023: € 487,396 ▲ 60% vs 2022 (€ 305,494) Favourable step	€ 654,656 Retained profit 2024: € 654,656 ▲ 34% vs 2023 (€ 487,396) Favourable step	€ 830,704 Retained profit 2025: € 830,704 ▲ 27% vs 2024 (€ 654,656) Favourable step	▲ 27%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 150,000 Dividend 2024: € 150,000 Unchanged (€ 0) Unchanged	€ 150,000 Dividend 2025: € 150,000 Unchanged (€ 150,000) Unchanged
Bank debt	€ 935,000 Bank debt 2022: € 935,000 First fiscal year in the series	€ 1,058,000 Bank debt 2023: € 1,058,000 ▲ 13% vs 2022 (€ 935,000) Unfavourable step	€ 581,000 Bank debt 2024: € 581,000 ▼ 45% vs 2023 (€ 1,058,000) Favourable step	€ 235,000 Bank debt 2025: € 235,000 ▼ 60% vs 2024 (€ 581,000) Favourable step	▼ 60%
Balance sheet total	€ 2,887,459 Balance sheet total 2022: € 2,887,459 First fiscal year in the series	€ 3,256,646 Balance sheet total 2023: € 3,256,646 ▲ 13% vs 2022 (€ 2,887,459) Unchanged	€ 2,981,213 Balance sheet total 2024: € 2,981,213 ▼ 8% vs 2023 (€ 3,256,646) Unchanged	€ 3,168,436 Balance sheet total 2025: € 3,168,436 ▲ 6% vs 2024 (€ 2,981,213) Unchanged	▲ 6%
Employees (FTE)	2.4 Employees (FTE) 2022: 2.4 First fiscal year in the series	2.6 Employees (FTE) 2023: 2.6 ▲ 0.2 vs 2022 (2.4) Unchanged	2.6 Employees (FTE) 2024: 2.6 Unchanged (2.6) Unchanged	2.7 Employees (FTE) 2025: 2.7 ▲ 0.1 vs 2024 (2.6) Unchanged	▲ 0.1

Key figures of BIO'OR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to BIO'OR?

What happened at BIO'OR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Rik Vandeputte stepped down as director. NBB
2027 Dries Ghekiere stepped down as director. NBB
2027 Francis Vandeputte stepped down as director. NBB
2027 Marnik Vanrolleghem stepped down as director. NBB
Dec 19, 2025 New annual accounts for financial year 2025: profit of € 326,048 (▲ 3% vs 2024). Source: NBB ↗
2021 Rik Vandeputte became a director. NBB
2021 Dries Ghekiere became a director. NBB
2021 Francis Vandeputte became a director. NBB

In short

From € 121,240 profit in 2022 to € 326,048 profit in 2025.

Paid € 338,588 in corporate taxes since 2022.

Best year ever: 2025, with € 326,048 profit.

On average € 275,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

LYSINVEST 70%

Sedasko 10%

The stake of LYSINVEST, Sedasko comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

BIO'OR

The shares are held by LYSINVEST (70%) and Sedasko (10%).

Directors

According to the 2025 annual accounts

Rik Vandeputte

Chairman of the board

Also active at: Belgian Feed Association, LEIEVOEDERS, CIVAR, DELTRAN, ULYSSE, DEL'OR, LYSINVEST, AgriKracht

since 2021 · until 2027

Dries Ghekiere

Managing director

since 2021 · until 2027

Francis Vandeputte

Director

Also active at: LEIEVOEDERS, CIVAR, LARIMOVA, DELTRAN, DEL'OR, LYSINVEST, AgriKracht

since 2021 · until 2027

Marnik Vanrolleghem

Director

Also active at: LEIEVOEDERS, CIVAR, DELTRAN, DEL'OR, LYSINVEST

since 2021 · until 2027

Shareholders

LYSINVEST

70%

Sedasko

10%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Vlamertingseweg 33

8970 Poperinge

2.275.662.461

Abeelseweg 144

8970 Poperinge

Active since 1 June 2018

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VEPA

€ 3,653 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0846.356.672

VAT number

BE 0846.356.672

Registered office

Vlamertingseweg 33, 8970 Poperinge

Names & denominations

BIO'OR

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

5 June 2012

Peppol

Active · Active since 12 Nov 2025

Activities · NACE

Vervaardiging van veevoeders

Handelsbemiddeling in de groothandel in landbouwgrondstoffen, levende dieren en textielgrondstoffen en halffabricaten

Groothandel in veevoeders

View on CBE Public ↗ Annual accounts (NBB) ↗

BIO'OR

Financials

What happened to BIO'OR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions